GLITARAY M 0.5MG

Glitaray-M 0.5 mg Tablet PR is classified within the group of medications known as antidiabetics. This formulation combines two active ingredients specifically formulated for the management of type 2 diabetes mellitus in adult patients. Its primary function is to assist individuals in maintaining their blood glucose levels within a normal range. For optimal results, it is advised that Glitaray-M 0.5 mg Tablet PR be consumed with food, and it should be taken consistently at the same time daily. The prescribing physician will determine the most appropriate dosage for each patient, and this may be adjusted based on the individual’s response and blood sugar monitoring. Continuation of this medication is important, even when feeling well or achieving stable blood glucose levels. Discontinuation without medical consultation could lead to a significant increase in blood sugar levels and heighten the risk of complications, including kidney issues, vision loss, nerve damage, and limb loss. This medication should be viewed as part of a comprehensive treatment plan that promotes a balanced diet, regular physical activity, and weight management as per medical guidance, as these lifestyle factors significantly impact diabetes control. One of the primary concerns associated with Glitaray-M 0.5 mg Tablet PR is the potential for hypoglycemia or low blood sugar. Patients should be aware of symptoms such as sweating, dizziness, headaches, and trembling, and be prepared to address them promptly. Consistent meal patterns and having quick sources of sugar available are advised to mitigate risks. Alcohol consumption may exacerbate the risk of low blood sugar and should therefore be avoided. Additional effects may include alterations in taste, feelings of nausea, diarrhea, abdominal discomfort, headaches, and respiratory infections. Some patients might experience weight gain while on this medication. It is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or significant renal or hepatic impairment. A thorough medical history, including any heart conditions, should be discussed with a healthcare provider prior to initiation of therapy. Regular monitoring of blood glucose and possibly blood tests to assess blood cell and liver health will likely be part of ongoing care.